Universal Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)-Producing and CD40L Expressing Bystander Cell Line for Tumor Vaccine in Melanoma
Clinical trial NCT00101166 · COMPLETED
Trial details
- NCT number
- NCT00101166
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-01
- Primary completion
- 2010-03-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.